blood sampling
blood sampling is a biological therapy with 585 clinical trials. Currently 140 active trials ongoing. Historical success rate of 93.6%.
Success Metrics
Based on 280 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
7
Mid Stage
33
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.2%
280 of 307 finished
8.8%
27 ended early
140
trials recruiting
585
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Decompensation of Cirrhosis and Iron Metabolism
Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.
COVID-19 Antibody Responses In Cystic Fibrosis
Clinical Trials (585)
Decompensation of Cirrhosis and Iron Metabolism
Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.
COVID-19 Antibody Responses In Cystic Fibrosis
Comparison of the BIG Score and the Pediatric Trauma Score
cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
Optimal Shock Energy for Electrical Cardioversion of Atrial Fibrillation
A Clinico-biological Database of Lung Cancers
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
Immuno-Genetic, Inflammation, Retro-Virus, Environment
Kinetics of INF-γ Production in Intensive Care Patients
Study of 18F-FFNP Breast PET/MRI
Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort
Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
Heterogeneity of Oral Carcinogenesis: From PrEneoplasia to Invasive Squamous Cell Carcinoma
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 585